Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
DNA Vaccines
Studies from Nanjing Medical University, Vaccine Research Center reveal new findings on DNA vaccines
November 12th, 2008
Research findings, 'The ability of Hepatitis B surface antigen DNA vaccine to elicit cell-mediated immune responses, but not antibody responses, was affected by the deglysosylation of S antigen,' are discussed in a new report. According to recent research from Nanjing, People's Republic of China, "Hepatitis B Virus (HBV) infection remains a major worldwide infectious disease with serious long-term morbidity and mortality. The limited selections of drug treatment are not able to control the progress of disease in people with active and persistent HBV infection." "Immunotherapy to control the degree of viral infection is one possible alternative solution to this...
Source: Vaccine Weekly (2008-11-12)
|
